Bayesian Capital Management’s Accenture ACN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-21,699
| Closed | -$5.35M | – | 116 |
|
|
2025
Q3 | $5.35M | Buy |
+21,699
| New | +$5.66M | 1.09% | 4 |
|
|
2025
Q1 | – | Sell |
-8,000
| Closed | -$2.81M | – | 573 |
|
|
2024
Q4 | $2.81M | Buy |
+8,000
| New | +$2.88M | 0.34% | 82 |
|
|
2024
Q3 | – | Sell |
-43,600
| Closed | -$13.2M | – | 646 |
|
|
2024
Q2 | $13.2M | Buy |
43,600
+19,900
| +84% | +$6.1M | 1.52% | 4 |
|
|
2024
Q1 | $8.21M | Buy |
+23,700
| New | +$8.64M | 0.79% | 11 |
|
|
2023
Q4 | – | Sell |
-12,907
| Closed | -$3.96M | – | 709 |
|
|
2023
Q3 | $3.96M | Buy |
+12,907
| New | +$4.07M | 0.45% | 49 |
|
|
2023
Q2 | – | Sell |
-7,640
| Closed | -$2.18M | – | 753 |
|
|
2023
Q1 | $2.18M | Buy |
7,640
+5,040
| +194% | +$1.37M | 0.27% | 99 |
|
|
2022
Q4 | $694K | Sell |
2,600
-4,510
| -63% | -$1.25M | 0.1% | 267 |
|
|
2022
Q3 | $1.83M | Buy |
+7,110
| New | +$2.05M | 0.37% | 53 |
|
|
2022
Q2 | – | Sell |
-1,233
| Closed | -$416K | – | 752 |
|
|
2022
Q1 | $416K | Sell |
1,233
-3,342
| -73% | -$1.13M | 0.06% | 430 |
|
|
2021
Q4 | $1.9M | Buy |
+4,575
| New | +$1.67M | 0.6% | 34 |
|
|
2021
Q1 | – | Sell |
-17,200
| Closed | -$4.49M | – | 519 |
|
|
2020
Q4 | $4.49M | Buy |
+17,200
| New | +$4.12M | 1.17% | 12 |
|
|
2020
Q3 | – | Sell |
-29,900
| Closed | -$6.42M | – | 498 |
|
|
2020
Q2 | $6.42M | Buy |
+29,900
| New | +$5.66M | 1.42% | 4 |
|
|
2019
Q4 | – | Sell |
-66,460
| Closed | -$12.8M | – | 581 |
|
|
2019
Q3 | $12.8M | Buy |
+66,460
| New | +$12.9M | 2.42% | 2 |
|
|
2019
Q2 | – | Sell |
-44,300
| Closed | -$7.8M | – | 489 |
|
|
2019
Q1 | $7.8M | Buy |
+44,300
| New | +$6.96M | 1.5% | 1 |
|
|
2018
Q3 | – | Sell |
-52,600
| Closed | -$8.61M | – | 610 |
|
|
2018
Q2 | $8.61M | Buy |
+52,600
| New | +$8.18M | 1.94% | 2 |
|
|
2018
Q1 | – | Sell |
-42,000
| Closed | -$6.43M | – | 558 |
|
|
2017
Q4 | $6.43M | Sell |
42,000
-11,319
| -21% | -$1.64M | 1.31% | 2 |
|
|
2017
Q3 | $7.2M | Buy |
+53,319
| New | +$6.95M | 1.72% | 1 |
|
|
2016
Q4 | – | Sell |
-7,600
| Closed | -$928K | – | 578 |
|
|
2016
Q3 | $928K | Buy |
+7,600
| New | +$865K | 0.61% | 29 |
|
|
2016
Q2 | – | Sell |
-8,105
| Closed | -$935K | – | 388 |
|
|
2016
Q1 | $935K | Buy |
+8,105
| New | +$832K | 0.88% | 4 |
|
Other funds holding ACN
Bayesian Capital Management's ACN Position: Q4 2025 in Review
Bayesian Capital Management sold out of Accenture (ACN) in Q4 2025, closing a stake of 21,699 shares — an estimated $5.35M sold.
Bayesian Capital Management first reported a position in ACN in Q1 2016 and held it in 19 quarters. The position peaked at $13.2M in Q2 2024. 2,362 funds tracked by Wall St. Rank hold ACN as of Q4 2025.
- Bayesian Capital Management reported no remaining Accenture position as of Q4 2025 after selling out during the quarter.
- Bayesian Capital Management sold 21,699 Accenture shares in Q4 2025, an estimated $5.35M.
- Bayesian Capital Management first reported a position in Accenture in Q1 2016 and held it in 19 quarters.
- Bayesian Capital Management's Accenture position peaked at $13.2M in Q2 2024.
- 2,362 funds tracked by Wall St. Rank held Accenture as of Q4 2025.
Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.